The global AI-driven Drug Discovery market was valued at US$ 716 million in 2023 and is anticipated to reach US$ 1372.6 million by 2030, witnessing a CAGR of 10.5% during the forecast period 2024-2030.

AI-driven Drug Discovery Market

AI, its end-to-end drug discovery platform using generative artificial intelligence to discover new targets, design new molecules, and predict the outcome of clinical trials.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for AI-driven Drug Discovery, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding AI-driven Drug Discovery.

Report Scope

The AI-driven Drug Discovery market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global AI-driven Drug Discovery market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the AI-driven Drug Discovery companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of AI-driven Drug Discovery Market Report

Report Metric	Details
Report Name	AI-driven Drug Discovery Market
Accounted market size in 2023	US$ 716 million
Forecasted market size in 2030	US$ 1372.6 million
CAGR	10.5%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	Small Molecule Drug Biological Modeling Structural Biology Others
Segment by Application	Pharmaceutical and Biotechnology Companies Research Laboratories
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Entos, Selvita, Benevolent, Exscientia, Euretos, Illumina with AstraZeneca, Novo Nordisk with Microsoft, Iktos, Aqemia, Zephyr AI, Cyclicarx, Eli Lilly, Terray Therapeutics, Ardigen, ReviveMed, Insilico Medicine, XtalPi, MindRank, DP Technology
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of AI-driven Drug Discovery companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is AI-driven Drug Discovery Market growing?

Ans: The AI-driven Drug Discovery Market witnessing a CAGR of 10.5% during the forecast period 2024-2030.

What is the AI-driven Drug Discovery Market size in 2030?

Ans: The AI-driven Drug Discovery Market size in 2030 will be US$ 1372.6 million.

Who are the main players in the AI-driven Drug Discovery Market report?

Ans: The main players in the AI-driven Drug Discovery Market are Entos, Selvita, Benevolent, Exscientia, Euretos, Illumina with AstraZeneca, Novo Nordisk with Microsoft, Iktos, Aqemia, Zephyr AI, Cyclicarx, Eli Lilly, Terray Therapeutics, Ardigen, ReviveMed, Insilico Medicine, XtalPi, MindRank, DP Technology

What are the Application segmentation covered in the AI-driven Drug Discovery Market report?

Ans: The Applications covered in the AI-driven Drug Discovery Market report are Pharmaceutical and Biotechnology Companies, Research Laboratories

What are the Type segmentation covered in the AI-driven Drug Discovery Market report?

Ans: The Types covered in the AI-driven Drug Discovery Market report are Small Molecule Drug, Biological Modeling, Structural Biology, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global AI-driven Drug Discovery Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Small Molecule Drug

1.2.3 Biological Modeling

1.2.4 Structural Biology

1.2.5 Others

1.3 Market by Application

1.3.1 Global AI-driven Drug Discovery Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Pharmaceutical and Biotechnology Companies

1.3.3 Research Laboratories

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global AI-driven Drug Discovery Market Perspective (2019-2030)

2.2 AI-driven Drug Discovery Growth Trends by Region

2.2.1 Global AI-driven Drug Discovery Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 AI-driven Drug Discovery Historic Market Size by Region (2019-2024)

2.2.3 AI-driven Drug Discovery Forecasted Market Size by Region (2025-2030)

2.3 AI-driven Drug Discovery Market Dynamics

2.3.1 AI-driven Drug Discovery Industry Trends

2.3.2 AI-driven Drug Discovery Market Drivers

2.3.3 AI-driven Drug Discovery Market Challenges

2.3.4 AI-driven Drug Discovery Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top AI-driven Drug Discovery Players by Revenue

3.1.1 Global Top AI-driven Drug Discovery Players by Revenue (2019-2024)

3.1.2 Global AI-driven Drug Discovery Revenue Market Share by Players (2019-2024)

3.2 Global AI-driven Drug Discovery Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by AI-driven Drug Discovery Revenue

3.4 Global AI-driven Drug Discovery Market Concentration Ratio

3.4.1 Global AI-driven Drug Discovery Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by AI-driven Drug Discovery Revenue in 2023

3.5 AI-driven Drug Discovery Key Players Head office and Area Served

3.6 Key Players AI-driven Drug Discovery Product Solution and Service

3.7 Date of Enter into AI-driven Drug Discovery Market

3.8 Mergers & Acquisitions, Expansion Plans

4 AI-driven Drug Discovery Breakdown Data by Type

4.1 Global AI-driven Drug Discovery Historic Market Size by Type (2019-2024)

4.2 Global AI-driven Drug Discovery Forecasted Market Size by Type (2025-2030)

5 AI-driven Drug Discovery Breakdown Data by Application

5.1 Global AI-driven Drug Discovery Historic Market Size by Application (2019-2024)

5.2 Global AI-driven Drug Discovery Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America AI-driven Drug Discovery Market Size (2019-2030)

6.2 North America AI-driven Drug Discovery Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America AI-driven Drug Discovery Market Size by Country (2019-2024)

6.4 North America AI-driven Drug Discovery Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe AI-driven Drug Discovery Market Size (2019-2030)

7.2 Europe AI-driven Drug Discovery Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe AI-driven Drug Discovery Market Size by Country (2019-2024)

7.4 Europe AI-driven Drug Discovery Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific AI-driven Drug Discovery Market Size (2019-2030)

8.2 Asia-Pacific AI-driven Drug Discovery Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific AI-driven Drug Discovery Market Size by Region (2019-2024)

8.4 Asia-Pacific AI-driven Drug Discovery Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America AI-driven Drug Discovery Market Size (2019-2030)

9.2 Latin America AI-driven Drug Discovery Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America AI-driven Drug Discovery Market Size by Country (2019-2024)

9.4 Latin America AI-driven Drug Discovery Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa AI-driven Drug Discovery Market Size (2019-2030)

10.2 Middle East & Africa AI-driven Drug Discovery Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa AI-driven Drug Discovery Market Size by Country (2019-2024)

10.4 Middle East & Africa AI-driven Drug Discovery Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Entos

11.1.1 Entos Company Detail

11.1.2 Entos Business Overview

11.1.3 Entos AI-driven Drug Discovery Introduction

11.1.4 Entos Revenue in AI-driven Drug Discovery Business (2019-2024)

11.1.5 Entos Recent Development

11.2 Selvita

11.2.1 Selvita Company Detail

11.2.2 Selvita Business Overview

11.2.3 Selvita AI-driven Drug Discovery Introduction

11.2.4 Selvita Revenue in AI-driven Drug Discovery Business (2019-2024)

11.2.5 Selvita Recent Development

11.3 Benevolent

11.3.1 Benevolent Company Detail

11.3.2 Benevolent Business Overview

11.3.3 Benevolent AI-driven Drug Discovery Introduction

11.3.4 Benevolent Revenue in AI-driven Drug Discovery Business (2019-2024)

11.3.5 Benevolent Recent Development

11.4 Exscientia

11.4.1 Exscientia Company Detail

11.4.2 Exscientia Business Overview

11.4.3 Exscientia AI-driven Drug Discovery Introduction

11.4.4 Exscientia Revenue in AI-driven Drug Discovery Business (2019-2024)

11.4.5 Exscientia Recent Development

11.5 Euretos

11.5.1 Euretos Company Detail

11.5.2 Euretos Business Overview

11.5.3 Euretos AI-driven Drug Discovery Introduction

11.5.4 Euretos Revenue in AI-driven Drug Discovery Business (2019-2024)

11.5.5 Euretos Recent Development

11.6 Illumina with AstraZeneca

11.6.1 Illumina with AstraZeneca Company Detail

11.6.2 Illumina with AstraZeneca Business Overview

11.6.3 Illumina with AstraZeneca AI-driven Drug Discovery Introduction

11.6.4 Illumina with AstraZeneca Revenue in AI-driven Drug Discovery Business (2019-2024)

11.6.5 Illumina with AstraZeneca Recent Development

11.7 Novo Nordisk with Microsoft

11.7.1 Novo Nordisk with Microsoft Company Detail

11.7.2 Novo Nordisk with Microsoft Business Overview

11.7.3 Novo Nordisk with Microsoft AI-driven Drug Discovery Introduction

11.7.4 Novo Nordisk with Microsoft Revenue in AI-driven Drug Discovery Business (2019-2024)

11.7.5 Novo Nordisk with Microsoft Recent Development

11.8 Iktos

11.8.1 Iktos Company Detail

11.8.2 Iktos Business Overview

11.8.3 Iktos AI-driven Drug Discovery Introduction

11.8.4 Iktos Revenue in AI-driven Drug Discovery Business (2019-2024)

11.8.5 Iktos Recent Development

11.9 Aqemia

11.9.1 Aqemia Company Detail

11.9.2 Aqemia Business Overview

11.9.3 Aqemia AI-driven Drug Discovery Introduction

11.9.4 Aqemia Revenue in AI-driven Drug Discovery Business (2019-2024)

11.9.5 Aqemia Recent Development

11.10 Zephyr AI

11.10.1 Zephyr AI Company Detail

11.10.2 Zephyr AI Business Overview

11.10.3 Zephyr AI AI-driven Drug Discovery Introduction

11.10.4 Zephyr AI Revenue in AI-driven Drug Discovery Business (2019-2024)

11.10.5 Zephyr AI Recent Development

11.11 Cyclicarx

11.11.1 Cyclicarx Company Detail

11.11.2 Cyclicarx Business Overview

11.11.3 Cyclicarx AI-driven Drug Discovery Introduction

11.11.4 Cyclicarx Revenue in AI-driven Drug Discovery Business (2019-2024)

11.11.5 Cyclicarx Recent Development

11.12 Eli Lilly

11.12.1 Eli Lilly Company Detail

11.12.2 Eli Lilly Business Overview

11.12.3 Eli Lilly AI-driven Drug Discovery Introduction

11.12.4 Eli Lilly Revenue in AI-driven Drug Discovery Business (2019-2024)

11.12.5 Eli Lilly Recent Development

11.13 Terray Therapeutics

11.13.1 Terray Therapeutics Company Detail

11.13.2 Terray Therapeutics Business Overview

11.13.3 Terray Therapeutics AI-driven Drug Discovery Introduction

11.13.4 Terray Therapeutics Revenue in AI-driven Drug Discovery Business (2019-2024)

11.13.5 Terray Therapeutics Recent Development

11.14 Ardigen

11.14.1 Ardigen Company Detail

11.14.2 Ardigen Business Overview

11.14.3 Ardigen AI-driven Drug Discovery Introduction

11.14.4 Ardigen Revenue in AI-driven Drug Discovery Business (2019-2024)

11.14.5 Ardigen Recent Development

11.15 ReviveMed

11.15.1 ReviveMed Company Detail

11.15.2 ReviveMed Business Overview

11.15.3 ReviveMed AI-driven Drug Discovery Introduction

11.15.4 ReviveMed Revenue in AI-driven Drug Discovery Business (2019-2024)

11.15.5 ReviveMed Recent Development

11.16 Insilico Medicine

11.16.1 Insilico Medicine Company Detail

11.16.2 Insilico Medicine Business Overview

11.16.3 Insilico Medicine AI-driven Drug Discovery Introduction

11.16.4 Insilico Medicine Revenue in AI-driven Drug Discovery Business (2019-2024)

11.16.5 Insilico Medicine Recent Development

11.17 XtalPi

11.17.1 XtalPi Company Detail

11.17.2 XtalPi Business Overview

11.17.3 XtalPi AI-driven Drug Discovery Introduction

11.17.4 XtalPi Revenue in AI-driven Drug Discovery Business (2019-2024)

11.17.5 XtalPi Recent Development

11.18 MindRank

11.18.1 MindRank Company Detail

11.18.2 MindRank Business Overview

11.18.3 MindRank AI-driven Drug Discovery Introduction

11.18.4 MindRank Revenue in AI-driven Drug Discovery Business (2019-2024)

11.18.5 MindRank Recent Development

11.19 DP Technology

11.19.1 DP Technology Company Detail

11.19.2 DP Technology Business Overview

11.19.3 DP Technology AI-driven Drug Discovery Introduction

11.19.4 DP Technology Revenue in AI-driven Drug Discovery Business (2019-2024)

11.19.5 DP Technology Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Illumina with AstraZeneca

Novo Nordisk with Microsoft

List of Tables

Table 1. Global AI-driven Drug Discovery Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Small Molecule Drug

Table 3. Key Players of Biological Modeling

Table 4. Key Players of Structural Biology

Table 5. Key Players of Others

Table 6. Global AI-driven Drug Discovery Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 7. Global AI-driven Drug Discovery Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 8. Global AI-driven Drug Discovery Market Size by Region (2019-2024) & (US$ Million)

Table 9. Global AI-driven Drug Discovery Market Share by Region (2019-2024)

Table 10. Global AI-driven Drug Discovery Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 11. Global AI-driven Drug Discovery Market Share by Region (2025-2030)

Table 12. AI-driven Drug Discovery Market Trends

Table 13. AI-driven Drug Discovery Market Drivers

Table 14. AI-driven Drug Discovery Market Challenges

Table 15. AI-driven Drug Discovery Market Restraints

Table 16. Global AI-driven Drug Discovery Revenue by Players (2019-2024) & (US$ Million)

Table 17. Global AI-driven Drug Discovery Market Share by Players (2019-2024)

Table 18. Global Top AI-driven Drug Discovery Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in AI-driven Drug Discovery as of 2023)

Table 19. Ranking of Global Top AI-driven Drug Discovery Companies by Revenue (US$ Million) in 2023

Table 20. Global 5 Largest Players Market Share by AI-driven Drug Discovery Revenue (CR5 and HHI) & (2019-2024)

Table 21. Key Players Headquarters and Area Served

Table 22. Key Players AI-driven Drug Discovery Product Solution and Service

Table 23. Date of Enter into AI-driven Drug Discovery Market

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global AI-driven Drug Discovery Market Size by Type (2019-2024) & (US$ Million)

Table 26. Global AI-driven Drug Discovery Revenue Market Share by Type (2019-2024)

Table 27. Global AI-driven Drug Discovery Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 28. Global AI-driven Drug Discovery Revenue Market Share by Type (2025-2030)

Table 29. Global AI-driven Drug Discovery Market Size by Application (2019-2024) & (US$ Million)

Table 30. Global AI-driven Drug Discovery Revenue Market Share by Application (2019-2024)

Table 31. Global AI-driven Drug Discovery Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 32. Global AI-driven Drug Discovery Revenue Market Share by Application (2025-2030)

Table 33. North America AI-driven Drug Discovery Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 34. North America AI-driven Drug Discovery Market Size by Country (2019-2024) & (US$ Million)

Table 35. North America AI-driven Drug Discovery Market Size by Country (2025-2030) & (US$ Million)

Table 36. Europe AI-driven Drug Discovery Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 37. Europe AI-driven Drug Discovery Market Size by Country (2019-2024) & (US$ Million)

Table 38. Europe AI-driven Drug Discovery Market Size by Country (2025-2030) & (US$ Million)

Table 39. Asia-Pacific AI-driven Drug Discovery Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 40. Asia-Pacific AI-driven Drug Discovery Market Size by Region (2019-2024) & (US$ Million)

Table 41. Asia-Pacific AI-driven Drug Discovery Market Size by Region (2025-2030) & (US$ Million)

Table 42. Latin America AI-driven Drug Discovery Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 43. Latin America AI-driven Drug Discovery Market Size by Country (2019-2024) & (US$ Million)

Table 44. Latin America AI-driven Drug Discovery Market Size by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa AI-driven Drug Discovery Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 46. Middle East & Africa AI-driven Drug Discovery Market Size by Country (2019-2024) & (US$ Million)

Table 47. Middle East & Africa AI-driven Drug Discovery Market Size by Country (2025-2030) & (US$ Million)

Table 48. Entos Company Detail

Table 49. Entos Business Overview

Table 50. Entos AI-driven Drug Discovery Product

Table 51. Entos Revenue in AI-driven Drug Discovery Business (2019-2024) & (US$ Million)

Table 52. Entos Recent Development

Table 53. Selvita Company Detail

Table 54. Selvita Business Overview

Table 55. Selvita AI-driven Drug Discovery Product

Table 56. Selvita Revenue in AI-driven Drug Discovery Business (2019-2024) & (US$ Million)

Table 57. Selvita Recent Development

Table 58. Benevolent Company Detail

Table 59. Benevolent Business Overview

Table 60. Benevolent AI-driven Drug Discovery Product

Table 61. Benevolent Revenue in AI-driven Drug Discovery Business (2019-2024) & (US$ Million)

Table 62. Benevolent Recent Development

Table 63. Exscientia Company Detail

Table 64. Exscientia Business Overview

Table 65. Exscientia AI-driven Drug Discovery Product

Table 66. Exscientia Revenue in AI-driven Drug Discovery Business (2019-2024) & (US$ Million)

Table 67. Exscientia Recent Development

Table 68. Euretos Company Detail

Table 69. Euretos Business Overview

Table 70. Euretos AI-driven Drug Discovery Product

Table 71. Euretos Revenue in AI-driven Drug Discovery Business (2019-2024) & (US$ Million)

Table 72. Euretos Recent Development

Table 73. Illumina with AstraZeneca Company Detail

Table 74. Illumina with AstraZeneca Business Overview

Table 75. Illumina with AstraZeneca AI-driven Drug Discovery Product

Table 76. Illumina with AstraZeneca Revenue in AI-driven Drug Discovery Business (2019-2024) & (US$ Million)

Table 77. Illumina with AstraZeneca Recent Development

Table 78. Novo Nordisk with Microsoft Company Detail

Table 79. Novo Nordisk with Microsoft Business Overview

Table 80. Novo Nordisk with Microsoft AI-driven Drug Discovery Product

Table 81. Novo Nordisk with Microsoft Revenue in AI-driven Drug Discovery Business (2019-2024) & (US$ Million)

Table 82. Novo Nordisk with Microsoft Recent Development

Table 83. Iktos Company Detail

Table 84. Iktos Business Overview

Table 85. Iktos AI-driven Drug Discovery Product

Table 86. Iktos Revenue in AI-driven Drug Discovery Business (2019-2024) & (US$ Million)

Table 87. Iktos Recent Development

Table 88. Aqemia Company Detail

Table 89. Aqemia Business Overview

Table 90. Aqemia AI-driven Drug Discovery Product

Table 91. Aqemia Revenue in AI-driven Drug Discovery Business (2019-2024) & (US$ Million)

Table 92. Aqemia Recent Development

Table 93. Zephyr AI Company Detail

Table 94. Zephyr AI Business Overview

Table 95. Zephyr AI AI-driven Drug Discovery Product

Table 96. Zephyr AI Revenue in AI-driven Drug Discovery Business (2019-2024) & (US$ Million)

Table 97. Zephyr AI Recent Development

Table 98. Cyclicarx Company Detail

Table 99. Cyclicarx Business Overview

Table 100. Cyclicarx AI-driven Drug Discovery Product

Table 101. Cyclicarx Revenue in AI-driven Drug Discovery Business (2019-2024) & (US$ Million)

Table 102. Cyclicarx Recent Development

Table 103. Eli Lilly Company Detail

Table 104. Eli Lilly Business Overview

Table 105. Eli Lilly AI-driven Drug Discovery Product

Table 106. Eli Lilly Revenue in AI-driven Drug Discovery Business (2019-2024) & (US$ Million)

Table 107. Eli Lilly Recent Development

Table 108. Terray Therapeutics Company Detail

Table 109. Terray Therapeutics Business Overview

Table 110. Terray Therapeutics AI-driven Drug Discovery Product

Table 111. Terray Therapeutics Revenue in AI-driven Drug Discovery Business (2019-2024) & (US$ Million)

Table 112. Terray Therapeutics Recent Development

Table 113. Ardigen Company Detail

Table 114. Ardigen Business Overview

Table 115. Ardigen AI-driven Drug Discovery Product

Table 116. Ardigen Revenue in AI-driven Drug Discovery Business (2019-2024) & (US$ Million)

Table 117. Ardigen Recent Development

Table 118. ReviveMed Company Detail

Table 119. ReviveMed Business Overview

Table 120. ReviveMed AI-driven Drug Discovery Product

Table 121. ReviveMed Revenue in AI-driven Drug Discovery Business (2019-2024) & (US$ Million)

Table 122. ReviveMed Recent Development

Table 123. Insilico Medicine Company Detail

Table 124. Insilico Medicine Business Overview

Table 125. Insilico Medicine AI-driven Drug Discovery Product

Table 126. Insilico Medicine Revenue in AI-driven Drug Discovery Business (2019-2024) & (US$ Million)

Table 127. Insilico Medicine Recent Development

Table 128. XtalPi Company Detail

Table 129. XtalPi Business Overview

Table 130. XtalPi AI-driven Drug Discovery Product

Table 131. XtalPi Revenue in AI-driven Drug Discovery Business (2019-2024) & (US$ Million)

Table 132. XtalPi Recent Development

Table 133. MindRank Company Detail

Table 134. MindRank Business Overview

Table 135. MindRank AI-driven Drug Discovery Product

Table 136. MindRank Revenue in AI-driven Drug Discovery Business (2019-2024) & (US$ Million)

Table 137. MindRank Recent Development

Table 138. DP Technology Company Detail

Table 139. DP Technology Business Overview

Table 140. DP Technology AI-driven Drug Discovery Product

Table 141. DP Technology Revenue in AI-driven Drug Discovery Business (2019-2024) & (US$ Million)

Table 142. DP Technology Recent Development

Table 143. Research Programs/Design for This Report

Table 144. Key Data Information from Secondary Sources

Table 145. Key Data Information from Primary Sources

List of Figures

Figure 1. Global AI-driven Drug Discovery Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global AI-driven Drug Discovery Market Share by Type: 2023 VS 2030

Figure 3. Small Molecule Drug Features

Figure 4. Biological Modeling Features

Figure 5. Structural Biology Features

Figure 6. Others Features

Figure 7. Global AI-driven Drug Discovery Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 8. Global AI-driven Drug Discovery Market Share by Application: 2023 VS 2030

Figure 9. Pharmaceutical and Biotechnology Companies Case Studies

Figure 10. Research Laboratories Case Studies

Figure 11. AI-driven Drug Discovery Report Years Considered

Figure 12. Global AI-driven Drug Discovery Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 13. Global AI-driven Drug Discovery Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 14. Global AI-driven Drug Discovery Market Share by Region: 2023 VS 2030

Figure 15. Global AI-driven Drug Discovery Market Share by Players in 2023

Figure 16. Global Top AI-driven Drug Discovery Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in AI-driven Drug Discovery as of 2023)

Figure 17. The Top 10 and 5 Players Market Share by AI-driven Drug Discovery Revenue in 2023

Figure 18. North America AI-driven Drug Discovery Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 19. North America AI-driven Drug Discovery Market Share by Country (2019-2030)

Figure 20. United States AI-driven Drug Discovery Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. Canada AI-driven Drug Discovery Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Europe AI-driven Drug Discovery Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Europe AI-driven Drug Discovery Market Share by Country (2019-2030)

Figure 24. Germany AI-driven Drug Discovery Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. France AI-driven Drug Discovery Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. U.K. AI-driven Drug Discovery Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. Italy AI-driven Drug Discovery Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Russia AI-driven Drug Discovery Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Nordic Countries AI-driven Drug Discovery Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Asia-Pacific AI-driven Drug Discovery Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Asia-Pacific AI-driven Drug Discovery Market Share by Region (2019-2030)

Figure 32. China AI-driven Drug Discovery Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Japan AI-driven Drug Discovery Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. South Korea AI-driven Drug Discovery Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Southeast Asia AI-driven Drug Discovery Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. India AI-driven Drug Discovery Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Australia AI-driven Drug Discovery Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Latin America AI-driven Drug Discovery Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Latin America AI-driven Drug Discovery Market Share by Country (2019-2030)

Figure 40. Mexico AI-driven Drug Discovery Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Brazil AI-driven Drug Discovery Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Middle East & Africa AI-driven Drug Discovery Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Middle East & Africa AI-driven Drug Discovery Market Share by Country (2019-2030)

Figure 44. Turkey AI-driven Drug Discovery Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Saudi Arabia AI-driven Drug Discovery Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Entos Revenue Growth Rate in AI-driven Drug Discovery Business (2019-2024)

Figure 47. Selvita Revenue Growth Rate in AI-driven Drug Discovery Business (2019-2024)

Figure 48. Benevolent Revenue Growth Rate in AI-driven Drug Discovery Business (2019-2024)

Figure 49. Exscientia Revenue Growth Rate in AI-driven Drug Discovery Business (2019-2024)

Figure 50. Euretos Revenue Growth Rate in AI-driven Drug Discovery Business (2019-2024)

Figure 51. Illumina with AstraZeneca Revenue Growth Rate in AI-driven Drug Discovery Business (2019-2024)

Figure 52. Novo Nordisk with Microsoft Revenue Growth Rate in AI-driven Drug Discovery Business (2019-2024)

Figure 53. Iktos Revenue Growth Rate in AI-driven Drug Discovery Business (2019-2024)

Figure 54. Aqemia Revenue Growth Rate in AI-driven Drug Discovery Business (2019-2024)

Figure 55. Zephyr AI Revenue Growth Rate in AI-driven Drug Discovery Business (2019-2024)

Figure 56. Cyclicarx Revenue Growth Rate in AI-driven Drug Discovery Business (2019-2024)

Figure 57. Eli Lilly Revenue Growth Rate in AI-driven Drug Discovery Business (2019-2024)

Figure 58. Terray Therapeutics Revenue Growth Rate in AI-driven Drug Discovery Business (2019-2024)

Figure 59. Ardigen Revenue Growth Rate in AI-driven Drug Discovery Business (2019-2024)

Figure 60. ReviveMed Revenue Growth Rate in AI-driven Drug Discovery Business (2019-2024)

Figure 61. Insilico Medicine Revenue Growth Rate in AI-driven Drug Discovery Business (2019-2024)

Figure 62. XtalPi Revenue Growth Rate in AI-driven Drug Discovery Business (2019-2024)

Figure 63. MindRank Revenue Growth Rate in AI-driven Drug Discovery Business (2019-2024)

Figure 64. DP Technology Revenue Growth Rate in AI-driven Drug Discovery Business (2019-2024)

Figure 65. Bottom-up and Top-down Approaches for This Report

Figure 66. Data Triangulation

Figure 67. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Stainless Steel Medication Trolley Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-18N15820

Wed Aug 28 00:00:00 UTC 2024

Add to Cart

Global Instant Molecular Testing Service Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-33G15638

Wed Aug 28 00:00:00 UTC 2024

Add to Cart

Global Universal Cell Therapy Drug Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-14U15769

Wed Aug 28 00:00:00 UTC 2024

Add to Cart

Global Preclinical Toxicology Testing Service Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-1P15930

Wed Aug 28 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions